Underdiagnosis and impact of menstrual migraine in real‐world clinical practice: A real‐world survey
This study highlights differences between patients with and without MM. Patients with MM experienced more severe attacks and reported lower treatment satisfaction, according to both patients and their physicians, compared to those without MM. Further real-world insights on patient experience, including migraine attack severity, are necessary to alleviate the burden of MM.
Authors
- Sophie Barlow (ORCID: https://orcid.org/0000-0001-5604-1360)
- Phillip Saccone
- Jessica Cirillo
- Karin Hygge Blakeman (ORCID: https://orcid.org/0000-0001-6925-7099)
- Lucy Abraham (ORCID: https://orcid.org/0000-0003-1648-8621)
- Gisela M. Terwindt (ORCID: https://orcid.org/0000-0003-3140-6882)
- Jessica Ailani (ORCID: https://orcid.org/0000-0001-8106-4927)
- Aaron Jenkins (ORCID: https://orcid.org/0000-0001-9785-9388)
- Feng Dai (ORCID: https://orcid.org/0000-0002-9963-6863)
- James Jackson (ORCID: https://orcid.org/0000-0002-4171-5390)
- Louise Hancock
- Boryana Galabova
- William Whitton (ORCID: https://orcid.org/0009-0004-8342-2125)
Institutions
- Pfizer (United States) (US)
- Georgetown University (US)
- Pfizer (United Kingdom) (GB)
- Leiden University Medical Center (NL)
- MedStar Georgetown University Hospital (US)
- Adelphi Group (United Kingdom) (GB)
- Pfizer (Sweden) (SE)
Publication Details
- Journal
- Headache The Journal of Head and Face Pain
- Published
- 2025-06-30
- DOI
- https://doi.org/10.1111/head.14996
- Citations
- 2
- Primary Topic
- Migraine and Headache Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.94